{"id":1314,"date":"2016-05-07T12:23:00","date_gmt":"2016-05-07T12:23:00","guid":{"rendered":"https:\/\/omalleytunstall.com\/?p=1314"},"modified":"2026-09-18T10:23:42","modified_gmt":"2026-09-18T10:23:42","slug":"la-empresa-farmaceutica-no-advirtio-a-los-pacientes-con-cancer-sobre-la-perdida-permanente-del-cabello","status":"publish","type":"post","link":"https:\/\/omalleytunstall.com\/es\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/","title":{"rendered":"La empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello"},"content":{"rendered":"<p>Varias demandas afirman que el fabricante de Taxotere (Sanofi-Aventis) no advirti\u00f3 a los pacientes ni a los m\u00e9dicos sobre los riesgos elevados de alopecia permanente (p\u00e9rdida de cabello) derivados del uso de Taxotere durante la quimioterapia. Si el fabricante hubiera advertido adecuadamente sobre los riesgos, a los pacientes se les habr\u00eda recetado un medicamento de quimioterapia diferente llamado Taxol, que es m\u00e1s eficaz que Taxotere y no provoca p\u00e9rdida permanente del cabello.<\/p>\n<p>Taxotere (docetaxel) es un medicamento de quimioterapia aprobado para el tratamiento del c\u00e1ncer de mama, el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as, el c\u00e1ncer de est\u00f3mago avanzado, el c\u00e1ncer de cabeza y cuello y el c\u00e1ncer de pr\u00f3stata metast\u00e1sico. Se administra por v\u00eda intravenosa a trav\u00e9s de una vena y pertenece a una familia de medicamentos llamados taxanos. Se utiliza para tratar de impedir que las c\u00e9lulas cancerosas crezcan y se dividan.<\/p>\n<p>Uno de los efectos secundarios, problemas y riesgos potenciales m\u00e1s graves y devastadores causados por el uso de Taxotere es la alopecia permanente (p\u00e9rdida de cabello).<\/p>\n<p>En diciembre de 2015, la Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. (FDA) reconoci\u00f3 que Taxotere puede provocar la p\u00e9rdida permanente del cabello, y esta advertencia se incluir\u00e1 ahora en la etiqueta de Taxotere.<\/p>\n<p>Puede resultar muy dif\u00edcil para un paciente y su m\u00e9dico determinar c\u00f3mo tratar un c\u00e1ncer. La mayor\u00eda de los tratamientos contra el c\u00e1ncer son t\u00f3xicos de alguna manera, y los riesgos del tratamiento deben sopesarse frente a los riesgos del c\u00e1ncer en s\u00ed. Puede ser muy complicado determinar el perfil de riesgos y beneficios de un tratamiento contra el c\u00e1ncer. Que un nuevo medicamento valga la pena a pesar de sus efectos secundarios depende de cada paciente en particular.<\/p>\n<p>No es que el medicamento tenga efectos secundarios, sino que el hecho de no haber advertido, a pesar de conocer estudios que demostraban que el medicamento ten\u00eda m\u00e1s probabilidades que otros medicamentos similares de provocar efectos secundarios graves, es lo que da lugar a las demandas.<\/p>\n<p><a href=\"https:\/\/omalleytunstall.com\/es\/joseph-p-tunstall-iii\/\">Joe Tunstall<\/a> En nuestra secci\u00f3n de responsabilidad por productos defectuosos, actualmente estamos analizando casos relacionados con el Taxotere y la alopecia permanente, as\u00ed como otros efectos secundarios graves, para nuestros clientes de Carolina del Norte, espec\u00edficamente porque el fabricante del medicamento no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello.<\/p>","protected":false},"excerpt":{"rendered":"<p>Several lawsuits states the manufacturer of Taxotere (Sanofi-Aventis) failed to warn patients and physicians of the increased risks of permanent alopecia (loss of hair) through the use of Taxotere during chemotherapy. If the manufacturer had properly warned of the risks, patients would have been prescribed a different chemotherapy drug called Taxol, which is more effective [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-1314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-products-liability"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug maker failed to warn Cancer patients of permanent hair loss | O&#039;Malley Tunstall PLLC<\/title>\n<meta name=\"description\" content=\"Drug maker failed to warn Cancer patients of permanent hair loss. Several lawsuits states the manufacturer of Taxotere ... Drug maker failed to warn Cancer patients of permanent hair loss\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/omalleytunstall.com\/es\/blog\/la-empresa-farmaceutica-no-advirtio-a-los-pacientes-con-cancer-sobre-la-perdida-permanente-del-cabello\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug maker failed to warn Cancer patients of permanent hair loss | O&#039;Malley Tunstall PLLC\" \/>\n<meta property=\"og:description\" content=\"Drug maker failed to warn Cancer patients of permanent hair loss. Several lawsuits states the manufacturer of Taxotere ... Drug maker failed to warn Cancer patients of permanent hair loss\" \/>\n<meta property=\"og:url\" content=\"https:\/\/omalleytunstall.com\/es\/blog\/la-empresa-farmaceutica-no-advirtio-a-los-pacientes-con-cancer-sobre-la-perdida-permanente-del-cabello\/\" \/>\n<meta property=\"og:site_name\" content=\"O\u2019Malley Tunstall, PC\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OMalleyTunstall\/\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/OMalleyTunstall\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-07T12:23:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-18T10:23:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"855\" \/>\n\t<meta property=\"og:image:height\" content=\"570\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"O\u2019Malley Tunstall, PC\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ncpilawyer\" \/>\n<meta name=\"twitter:site\" content=\"@ncpilawyer\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"O\u2019Malley Tunstall, PC\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/\"},\"author\":{\"name\":\"O\u2019Malley Tunstall, PC\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/#\\\/schema\\\/person\\\/040e260fe968de7714f5020de6d991d5\"},\"headline\":\"Drug maker failed to warn Cancer patients of permanent hair loss\",\"datePublished\":\"2016-05-07T12:23:00+00:00\",\"dateModified\":\"2026-09-18T10:23:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/\"},\"wordCount\":335,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp\",\"articleSection\":[\"Products Liability\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/\",\"url\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/\",\"name\":\"Drug maker failed to warn Cancer patients of permanent hair loss | O'Malley Tunstall PLLC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp\",\"datePublished\":\"2016-05-07T12:23:00+00:00\",\"dateModified\":\"2026-09-18T10:23:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/#\\\/schema\\\/person\\\/040e260fe968de7714f5020de6d991d5\"},\"description\":\"Drug maker failed to warn Cancer patients of permanent hair loss. Several lawsuits states the manufacturer of Taxotere ... Drug maker failed to warn Cancer patients of permanent hair loss\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#primaryimage\",\"url\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp\",\"contentUrl\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/uploads\\\/2016\\\/05\\\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp\",\"width\":855,\"height\":570,\"caption\":\"Drug maker failed to warn Cancer patients of permanent hair loss\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/blog\\\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/omalleytunstall.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug maker failed to warn Cancer patients of permanent hair loss\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/#website\",\"url\":\"https:\\\/\\\/omalleytunstall.com\\\/\",\"name\":\"O\u2019Malley Tunstall, PC\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/omalleytunstall.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/#\\\/schema\\\/person\\\/040e260fe968de7714f5020de6d991d5\",\"name\":\"O\u2019Malley Tunstall, PC\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/litespeed\\\/avatar\\\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612\",\"url\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/litespeed\\\/avatar\\\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612\",\"contentUrl\":\"https:\\\/\\\/omalleytunstall.com\\\/wp-content\\\/litespeed\\\/avatar\\\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612\",\"caption\":\"O\u2019Malley Tunstall, PC\"},\"description\":\"O\u2019Malley Tunstall, PC is a dedicated North Carolina personal injury and disability law firm with offices in Raleigh, Rocky Mount, Kinston, and across the state. For decades, our legal team has fought fiercely for injured individuals and their families, handling complex cases spanning personal injury, medical malpractice, product liability, and Social Security Disability. We prepare every case as if it\u2019s heading to trial to ensure our clients get the justice and compensation they deserve.\",\"sameAs\":[\"https:\\\/\\\/omalleytunstall.com\",\"https:\\\/\\\/www.facebook.com\\\/OMalleyTunstall\\\/\",\"https:\\\/\\\/clutch.co\\\/profile\\\/omalley-tunstall-pllc\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/omalley-tunstall-pc\",\"https:\\\/\\\/x.com\\\/ncpilawyer\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/NCLawyers\"],\"url\":\"https:\\\/\\\/omalleytunstall.com\\\/es\\\/blog\\\/author\\\/omalley-tunstall-pc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Una empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello | O'Malley Tunstall PLLC","description":"La empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello. Varias demandas afirman que el fabricante de Taxotere... La empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/omalleytunstall.com\/es\/blog\/la-empresa-farmaceutica-no-advirtio-a-los-pacientes-con-cancer-sobre-la-perdida-permanente-del-cabello\/","og_locale":"es_MX","og_type":"article","og_title":"Drug maker failed to warn Cancer patients of permanent hair loss | O'Malley Tunstall PLLC","og_description":"Drug maker failed to warn Cancer patients of permanent hair loss. Several lawsuits states the manufacturer of Taxotere ... Drug maker failed to warn Cancer patients of permanent hair loss","og_url":"https:\/\/omalleytunstall.com\/es\/blog\/la-empresa-farmaceutica-no-advirtio-a-los-pacientes-con-cancer-sobre-la-perdida-permanente-del-cabello\/","og_site_name":"O\u2019Malley Tunstall, PC","article_publisher":"https:\/\/www.facebook.com\/OMalleyTunstall\/","article_author":"https:\/\/www.facebook.com\/OMalleyTunstall\/","article_published_time":"2016-05-07T12:23:00+00:00","article_modified_time":"2026-09-18T10:23:42+00:00","og_image":[{"width":855,"height":570,"url":"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp","type":"image\/webp"}],"author":"O\u2019Malley Tunstall, PC","twitter_card":"summary_large_image","twitter_creator":"@ncpilawyer","twitter_site":"@ncpilawyer","twitter_misc":{"Escrito por":"O\u2019Malley Tunstall, PC","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#article","isPartOf":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/"},"author":{"name":"O\u2019Malley Tunstall, PC","@id":"https:\/\/omalleytunstall.com\/#\/schema\/person\/040e260fe968de7714f5020de6d991d5"},"headline":"Drug maker failed to warn Cancer patients of permanent hair loss","datePublished":"2016-05-07T12:23:00+00:00","dateModified":"2026-09-18T10:23:42+00:00","mainEntityOfPage":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/"},"wordCount":335,"commentCount":0,"image":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp","articleSection":["Products Liability"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/","url":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/","name":"Una empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello | O'Malley Tunstall PLLC","isPartOf":{"@id":"https:\/\/omalleytunstall.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#primaryimage"},"image":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp","datePublished":"2016-05-07T12:23:00+00:00","dateModified":"2026-09-18T10:23:42+00:00","author":{"@id":"https:\/\/omalleytunstall.com\/#\/schema\/person\/040e260fe968de7714f5020de6d991d5"},"description":"La empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello. Varias demandas afirman que el fabricante de Taxotere... La empresa farmac\u00e9utica no advirti\u00f3 a los pacientes con c\u00e1ncer sobre la p\u00e9rdida permanente del cabello","breadcrumb":{"@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#primaryimage","url":"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp","contentUrl":"https:\/\/omalleytunstall.com\/wp-content\/uploads\/2016\/05\/Drug-maker-failed-to-warn-Cancer-patients-of-permanent-hair-loss_1092932342.webp","width":855,"height":570,"caption":"Drug maker failed to warn Cancer patients of permanent hair loss"},{"@type":"BreadcrumbList","@id":"https:\/\/omalleytunstall.com\/blog\/drug-maker-failed-to-warn-cancer-patients-of-permanent-hair-loss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/omalleytunstall.com\/"},{"@type":"ListItem","position":2,"name":"Drug maker failed to warn Cancer patients of permanent hair loss"}]},{"@type":"WebSite","@id":"https:\/\/omalleytunstall.com\/#website","url":"https:\/\/omalleytunstall.com\/","name":"O\u2019Malley Tunstall, PC","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/omalleytunstall.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/omalleytunstall.com\/#\/schema\/person\/040e260fe968de7714f5020de6d991d5","name":"O\u2019Malley Tunstall, PC","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/omalleytunstall.com\/wp-content\/litespeed\/avatar\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612","url":"https:\/\/omalleytunstall.com\/wp-content\/litespeed\/avatar\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612","contentUrl":"https:\/\/omalleytunstall.com\/wp-content\/litespeed\/avatar\/369c4476c37dfb623c002e8725051711.jpg?ver=1792867612","caption":"O\u2019Malley Tunstall, PC"},"description":"O\u2019Malley Tunstall, PC es un bufete de abogados de Carolina del Norte especializado en lesiones personales e incapacidad, con oficinas en Raleigh, Rocky Mount, Kinston y en todo el estado. Durante d\u00e9cadas, nuestro equipo legal ha luchado con firmeza por las personas lesionadas y sus familias, manejando casos complejos que abarcan lesiones personales, negligencia m\u00e9dica, responsabilidad por productos defectuosos e incapacidad del Seguro Social. Preparamos cada caso como si fuera a llegar a juicio para asegurarnos de que nuestros clientes obtengan la justicia y la indemnizaci\u00f3n que merecen.","sameAs":["https:\/\/omalleytunstall.com","https:\/\/www.facebook.com\/OMalleyTunstall\/","https:\/\/clutch.co\/profile\/omalley-tunstall-pllc","https:\/\/www.linkedin.com\/company\/omalley-tunstall-pc","https:\/\/x.com\/ncpilawyer","https:\/\/www.youtube.com\/user\/NCLawyers"],"url":"https:\/\/omalleytunstall.com\/es\/blog\/author\/omalley-tunstall-pc\/"}]}},"_links":{"self":[{"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/posts\/1314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/comments?post=1314"}],"version-history":[{"count":3,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/posts\/1314\/revisions"}],"predecessor-version":[{"id":2901,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/posts\/1314\/revisions\/2901"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/media\/3029"}],"wp:attachment":[{"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/media?parent=1314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/categories?post=1314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omalleytunstall.com\/es\/wp-json\/wp\/v2\/tags?post=1314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}